These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 23496201)
1. Regadenoson for myocardial perfusion scintigraphy. Reyes E; Pennell DJ Expert Opin Med Diagn; 2010 Sep; 4(5):447-54. PubMed ID: 23496201 [TBL] [Abstract][Full Text] [Related]
2. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications. Palani G; Ananthasubramaniam K Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345 [TBL] [Abstract][Full Text] [Related]
3. Regadenoson in the detection of coronary artery disease. Buhr C; Gössl M; Erbel R; Eggebrecht H Vasc Health Risk Manag; 2008; 4(2):337-40. PubMed ID: 18561509 [TBL] [Abstract][Full Text] [Related]
4. Advances in pharmacologic stress agents: focus on regadenoson. Johnson SG; Peters S J Nucl Med Technol; 2010 Sep; 38(3):163-71. PubMed ID: 20724531 [TBL] [Abstract][Full Text] [Related]
6. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole. Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331 [TBL] [Abstract][Full Text] [Related]
7. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Cerqueira MD Am J Cardiol; 2004 Jul; 94(2A):33D-40D; discussion 40D-42D. PubMed ID: 15261132 [TBL] [Abstract][Full Text] [Related]
8. Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases. Reyes E; Richard Underwood S J Nucl Cardiol; 2020 Feb; 27(1):315-321. PubMed ID: 31797320 [TBL] [Abstract][Full Text] [Related]
10. Acute myocardial infarction during regadenoson myocardial perfusion imaging. Shah S; Parra D; Rosenstein RS Pharmacotherapy; 2013 Jun; 33(6):e90-5. PubMed ID: 23471769 [TBL] [Abstract][Full Text] [Related]
11. Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson. Noel CV; Krishnamurthy R; Moffett B; Krishnamurthy R Pediatr Radiol; 2017 Mar; 47(3):280-289. PubMed ID: 28035425 [TBL] [Abstract][Full Text] [Related]
12. Regadenoson: a new myocardial stress agent. Al Jaroudi W; Iskandrian AE J Am Coll Cardiol; 2009 Sep; 54(13):1123-30. PubMed ID: 19761931 [TBL] [Abstract][Full Text] [Related]
13. Rapid detection of coronary artery stenoses with real-time perfusion echocardiography during regadenoson stress. Porter TR; Adolphson M; High RR; Smith LM; Olson J; Erdkamp M; Xie F; O'Leary E; Wong BF; Eifert-Rain S; Hagen ME; Abdelmoneim SS; Mulvagh SL Circ Cardiovasc Imaging; 2011 Nov; 4(6):628-35. PubMed ID: 21946702 [TBL] [Abstract][Full Text] [Related]
14. Regadenoson in Myocardial Perfusion Study - First Institutional Experiences in Bosnia and Herzegovina. Beslic N; Milardovic R; Sadija A; Ceric S; Raic Z Acta Inform Med; 2016 Dec; 24(6):405-408. PubMed ID: 28077904 [TBL] [Abstract][Full Text] [Related]
15. A rare complication of a common stress test. Junpaparp P; Rammohan HRS; Buppajarntham S; Figueredo VM J Cardiol Cases; 2014 Aug; 10(2):43-45. PubMed ID: 30546501 [TBL] [Abstract][Full Text] [Related]
16. Patient- and clinician-reported satisfaction with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). Hudgens S; Breeze J; Spalding J J Med Econ; 2013; 16(6):828-34. PubMed ID: 23614479 [TBL] [Abstract][Full Text] [Related]
18. Age and gender as predictors of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: a substudy of the ASSUAGE trial. Rangel MO; Demori RM; Doukky R Am J Ther; 2013; 20(6):622-9. PubMed ID: 24100259 [TBL] [Abstract][Full Text] [Related]